Literature DB >> 10495627

[Basic principles of clinical trials--what, how, and why?].

K Unnebrink1, M Pritsch.   

Abstract

Treatment evaluation is one of the most important tasks in medical research. Detailed standards have been developed during the last decades. The efficacy/effectiveness of treatments can only be assessed in comparison to control groups. To guarantee the internal validity of these comparisons, the groups have to be comparable at the beginning of the study. This can be achieved by randomized allocation of patients to treatment. Furthermore, as far as possible patient and physician should be blinded to treatment in order to avoid subjective influences on treatment results. Groups should still be comparable when analysing the trial, thus an analysis according to the principle of intention-to-treat ("as randomized") should be performed. These indispensable principles for design, conduct and analysis of clinical trials are widely accepted and contribute to reliable and credible results.

Entities:  

Mesh:

Year:  1999        PMID: 10495627     DOI: 10.1007/BF03044732

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  12 in total

1.  Introducing a placebo needle into acupuncture research.

Authors:  K Streitberger; J Kleinhenz
Journal:  Lancet       Date:  1998-08-01       Impact factor: 79.321

Review 2.  [Requirements of patient-oriented clinical-therapeutic research].

Authors:  H Schäfer
Journal:  Dtsch Med Wochenschr       Date:  1997-12-05       Impact factor: 0.628

3.  Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis.

Authors:  W Skassa-Brociek; J Bousquet; F Montes; M Verdier; D Schwab; M Lherminier; F B Michel
Journal:  J Allergy Clin Immunol       Date:  1988-04       Impact factor: 10.793

4.  Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.

Authors:  R G Wilcox; J M Roland; D C Banks; J R Hampton; J R Mitchell
Journal:  Br Med J       Date:  1980-03-29

5.  Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group.

Authors:  R R Berges; J Windeler; H J Trampisch; T Senge
Journal:  Lancet       Date:  1995-06-17       Impact factor: 79.321

6.  Long-term, placebo-controlled trial of ketotifen in the management of preschool children with asthma.

Authors:  B G Loftus; J F Price
Journal:  J Allergy Clin Immunol       Date:  1987-02       Impact factor: 10.793

7.  Randomized versus historical controls for clinical trials.

Authors:  H Sacks; T C Chalmers; H Smith
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

8.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Authors:  A R Feinstein; D M Sosin; C K Wells
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

9.  Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.

Authors:  J B Vermorken; A M Claessen; H van Tinteren; H E Gall; R Ezinga; S Meijer; R J Scheper; C J Meijer; E Bloemena; J H Ransom; M G Hanna; H M Pinedo
Journal:  Lancet       Date:  1999-01-30       Impact factor: 79.321

10.  Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.

Authors: 
Journal:  N Engl J Med       Date:  1980-10-30       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.